Question 1

What is Entyvio (vedolizumab)?

Accepted Answer

Entyvio is the brand name for vedolizumab, a monoclonal antibody developed by Millennium Pharmaceuticals to treat ulcerative colitis and Crohn's disease.

Question 2

How many companies research Entyvio (vedolizumab)?

Accepted Answer

Based on our data, 52 companies research Entyvio (vedolizumab). This number is updated daily as we discover new companies through job posting analysis.

Question 3

What types of companies research Entyvio (vedolizumab)?

Accepted Answer

Entyvio (vedolizumab) is relevant across multiple industries including Pharmaceutical Manufacturing, Hospitals and Health Care, Higher Education. Companies range from startups to enterprises with 10,000+ employees.

Question 4

How does TheirStack track companies related to Entyvio (vedolizumab)?

Accepted Answer

TheirStack analyzes millions of job postings daily from company career pages, job boards, and recruitment platforms. When a company mentions Entyvio (vedolizumab) in their job descriptions, requirements, or responsibilities, we identify them as related to Entyvio (vedolizumab) and add them to our database.

Question 5

How can I get the full list of companies that research Entyvio (vedolizumab)?

Accepted Answer

You can access the complete list of 52 companies on TheirStack. The data includes company name, industry, size, location, funding, and revenue. Available via our web app or API.

Question 6

How often is the company data updated?

Accepted Answer

Our database is refreshed daily. We continuously monitor job postings to detect new companies researching Entyvio (vedolizumab) and update existing records.

Company	Country	Industry	Employees	Revenue	Technologies
ConnectiveRx	United States	Pharmaceutical Manufacturing	1.4k	$300M	Entyvio (vedolizumab)
Revitalized, LLC: Specialty Infusion Services	United States	Hospitals and Health Care	28		Entyvio (vedolizumab)
Takeda	Japan	Pharmaceutical Manufacturing	37k	$31B	Entyvio (vedolizumab)
Gastroenterology Specialties, PC	United States	Hospitals and Health Care	201	$12M	Entyvio (vedolizumab)
Washington University in St. Louis	United States	Higher Education	15k	$3.7B	Entyvio (vedolizumab)
Johns Hopkins Medical Management Corporation	United States	Medical Practices	8		Entyvio (vedolizumab)
Northeastern Vermont Regional Hospital	United States	Hospitals and Health Care	501	$10M	Entyvio (vedolizumab)
US Digestive Health	United States	Hospitals and Health Care	286	$25M	Entyvio (vedolizumab)
UC San Diego Health	United States	Hospitals and Health Care	32k	$136M	Entyvio (vedolizumab)
Vital Care of Las Cruces	United States	Hospitals and Health Care	3	$24M	Entyvio (vedolizumab)

Companies researching Entyvio (vedolizumab)

List of companies that research Entyvio (vedolizumab)